Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Radiother Oncol. 2023 Nov 14;190:110005. doi: 10.1016/j.radonc.2023.110005

Fig. 1.

Fig. 1.

Cumulative incidence of major adverse cardiac events, (A) among all patients and stratified by baseline coronary heart disease (CHD); (B-D) stratified by LAD V15Gy ≥ 10 % (B) among all patients, (C) among patients with baseline CHD, and (D) among patients without baseline CHD.